Notably, subgroup analysis in patients with non-viral ME/CFS onset was limited by low enrollment, reducing the power to detect changes in pSer258-ATG13 expression. The gene discussed is ATG13; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.